Huiren Group Co., Ltd., founded in 1992, is a well-known trademark in Jiangxi Province and a large-scale pharmaceutical group known for its Kidney Bao Kidney Supplement Products/Wuji Baifeng Pills/Liuwei Dihuang Pill series products
Founded in 2003, Huiren Pharmaceutical Co., Ltd. is a large-scale pharmaceutical enterprise in China with integrated development according to the expansion of the health industry chain and the combination of production, education and research. Headquartered in the historic city of Nanchang, Jiangxi, it has more than 2,000 employees.
Adhering to the core concept of "benevolence loves others", Huiren Pharmaceutical has embarked on a unique road of health industry development, and the comprehensive economic strength of the enterprise has been rapidly improved. Chen Shishi, president of the company, was elected as a representative of the 10th and 11th National People's Congress.
1. Scientific and technological innovation and energy storage
Scientific and technological strength is the inexhaustible driving force for the development of enterprises. Huiren Pharmaceutical adheres to the development concept of "committed to the revitalization of national medicine" and "science and technology is the primary productive force", and has invested heavily in the construction of a national R&D center in Shanghai Zhangjiang High-tech Park, China's medicine valley, which has a modern pilot platform open to the whole country and a large number of international leading level instruments and facilities. It has successively introduced high-level medical research talents such as doctoral supervisors, postdoctoral fellows, and doctors, and established postdoctoral workstations. Every year, a certain proportion of sales revenue is withdrawn from scientific research funds for product research and development, scientific and technological innovation and transformation of scientific and technological achievements.
After the R&D institutions settled in Shanghai, they actively carried out new products and new technologies with the new drug R&D model of independent innovation and industry-university-research combination, completed dozens of drug research and development tasks, undertook more than 10 national scientific and technological research projects and a number of national scientific research projects, and maintained good research and development cooperation with the Life Science Development Center of the Ministry of Science and Technology, China Academy of Traditional Chinese Medicine, China Pharmaceutical Research and Development Center, China Pharmaceutical University, Shanghai University of Traditional Chinese Medicine and other well-known domestic research institutions and institutions. And a large number of research results have been obtained.
Strong R&D capabilities ensure the high quality of Huiren products and continuously launch new products with definite efficacy, affordable prices and popular with consumers. At present, Huiren Pharmaceutical Co., Ltd. has more than 10 series and more than 100 specifications of product groups, such as kidney tonic drugs such as Kidney Treasure Mixture, Kidney Treasure Tablets, and Yinyang Suo, gynecological pediatrics, antibiotics, digestive system, circulatory system Chinese patent medicines and chemical drugs.
2. Benevolence is the common development
Huiren Pharmaceutical has always taken "benevolence loves people" as the core concept of the enterprise, and for more than ten years, the concept of "benevolence loves others" has been implemented and sublimated in Huiren.
As far as Huiren is concerned, "benevolence loves people" is first of all responsible for consumers and provides consumers with pharmaceutical products with reliable quality and definite efficacy. In accordance with the high starting point planning, Huiren has invested hundreds of millions of yuan to build a production base according to GMP standards, and all dosage form workshops have passed GMP demonstration, and invested heavily in the introduction of international advanced production equipment and quality testing instruments from Germany, Italy and other places. In the process of product production and testing, Huiren uses a large number of domestic or international leading advanced technologies at any cost to ensure the high quality of products and meet the needs of the people. The Chinese patent medicine produced by Huiren has become the leading product in the pharmaceutical market, and dozens of commonly used drugs in tonic, gynecology, digestion and antibiotics occupy a considerable market share. It is recognized by the majority of consumers as a good and reliable medicine that the people can afford.
"Benevolence and love" is also reflected in caring for employees and caring for their well-being. Huiren Pharmaceutical has set up a trade union committee to recruit all employees as trade union members, and carry out a variety of activities through the trade union to care for the work and life of employees. Since its establishment, Huiren has attached great importance to the construction of corporate culture, and has paid attention to improving the ideological quality and scientific and cultural quality of employees through publicity methods such as "Huiren Daily". Every year, a considerable amount of special funds are allocated as staff training funds, focusing on cultivating high-quality professional managers, and striving to create space for employee development.
"Benevolence and love for others" is more embodied in selfless contributions to the country and society. The company regards "revitalizing the economy of one party and benefiting the people of one party" as the corporate social values of Huiren, and regards giving back to the society as its unshirkable responsibility. Over the past ten years, Huiren has paid taxes from the initial hundreds of thousands of yuan to more than 100 million yuan now, and has accumulated more than 1 billion yuan in national taxes. More than 10,000 laid-off and unemployed people have been trained and resettled, relieving the pressure on social employment for the government.
3. Strategic transformation for the future
The pharmaceutical industry has achieved good results in the environment of rising labor and raw material costs. The marketing of leading products such as Kidney Treasure Tablets and Yinyangsuo, OTC business products and prescription drug products continued to be deepened, and the domestic market was carried out. At the same time, Huiren Pharmaceutical is actively preparing for listing. In 2013, in order to meet the development needs, the construction project of the new plant of the group drug production base officially kicked off, the new plant is located in the east of Jinsha 3rd Road, west of Jinsha 2nd Road, south of Huiren Avenue and north of Yinhu 2nd Road in Xiaolan Industrial Park, with a total investment of 700 million yuan and an area of 403 acres. After completion, the new factory area includes a dignified and elegant comprehensive office building, a GMP-compliant production workshop, a high-tech logistics warehouse, a fully equipped staff dormitory and a multi-functional staff activity center. The construction project of the new plant is divided into three phases. The first phase of the project has a construction area of 120,000 square meters and an investment of 350 million yuan, which has been completed and put into operation at the end of 2015. After the new plant is completed and put into operation, the whole production process will adopt the digital production and quality management system, and through the means of informatization, the most error-prone factor "personnel" in the GMP system will be effectively managed, so as to reduce the errors of human operation, so that the new version of GMP can be fully and effectively implemented into the electronic control of the enterprise, realize the intelligent and informatization of the pharmaceutical process, greatly improve the level of drug production process and equipment and the quality of drug production, provide new employment opportunities for the local government, and provide good support for the increase of national tax revenue. It will lay a solid foundation for the rapid development of Huiren Pharmaceutical in the future.
Only by constantly optimizing the model, improving the system and refining the culture will we inject endless vitality into the development of Huiren, a national brand that integrates the connotation of Chinese humanities tradition and modern medical science and technology. Huiren, an enterprise with core competitiveness and a bright future, will continue to uphold the core concept of "benevolence loves others", deeply cultivate the land of China in a down-to-earth manner, and create a grand cause.
